Identification of novel markers for the identification of visceral leishmaniasis  by Kumar, D. & Sundar, S.
16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460 385
Type: Poster Presentation
Final Abstract Number: 59.051
Session: Diagnosis
Date: Saturday, April 5, 2014
Time: 12:45-14:15
Room: Ballroom
Identiﬁcation of novel markers for the
identiﬁcation of visceral leishmaniasis
D. Kumar ∗, S. Sundar
BANARAS HINDU UNIVERSITY, Varanasi, India
Background: Visceral leishmaniasis (VL) is an infection trans-
mitted by phlebotomine ﬂies and caused by parasite of the genus
Leishmania. This disease is characterised by fever, weight loss,
enlargementof the liver, spleenand lymphnodesand lowbloodcell
count. Early and accurate laboratory diagnosis is essential before
initiating treatment, for clinical outcome reasons. The clinical fea-
tures of VL resembles those of several other disease including
malaria, tuberculosis etc, effective drug are available but they need
to be administered for aminimum3weeks and are potentially toxic
and expensive.For diagnosis of VL, rK39 antigen based rapid test
is widely used. Unfortunately, up to 32% healthy individuals from
endemic region test positive with this antigen in Indian subconti-
nent. There is an urgent need to search for a more speciﬁc antigen
withmoreprecise speciﬁcity but sensitivity similar to rK39antigen.
Methods & Materials: We identiﬁed L. donovani speciﬁc 70kDa
(BHUP1), 37kDa (BHUP2), 12.6kDa (BHUP3) soluble promastigote
antigen throughwestern blot technique, in order to develop a diag-
nosticmarker for VL. On blotting, antibody against this proteinwas
recognized by all VL patient’s sera, but, it was absent in every con-
trol group non-endemic healthy control (NEHC), endemic healthy
control (EHC) and different disease (DD). The diagnostic potential
was further validated by ELISA using serum of VL, NEHC, EHC and
DDs.
Results: The Sensitivity of the ELISA were found to be for VL
(96%, 95%, 88%), whereas the speciﬁcity ranges for EHC (96%, 98%
and 96%), NEHC (100% for three antigen) and DD (97%, 97% and
97.4%) groups respectively, against BHUP1, BHUP2, BHUP3 anti-
gen respectively. Furthermore, it was characterized by 2D-PAGE
analysis followed by MALDI-TOF analysis.
Conclusion: Due to excellent sensitivity and speciﬁcity of these
antigens, itwarrants the further development as a tool for diagnosis
of VL
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A comparative evaluation of rapid
immunochromatographic test for VL - whole
blood vs serum
D. Kumar ∗, S. Sundar
BANARAS HINDU UNIVERSITY, Varanasi, India
Background: Diagnosis of leishmaniasis is still a challenge in
front of investigator. A ﬁrmdiagnosis of visceral leishmaniasis (kala
azar) requires demonstration of the parasite in organ aspirates or
tissue biopsy samples. The aim of this prospective study was to
assess the diagnostic usefulness of non-invasive testing for anti-
body to the leishmanial antigen by means of antigen-impregnated
nitrocellulose paper strips adapted for use under ﬁeld as well as
laboratory conditions. There are so many rapid diagnostic tests
(RDTs) of differentbrandsavailable andpublished report of variable
accuracy.
Methods & Materials: This study of evaluation includes six
commercially available VL-RDTs of four different manufacturers.
These VL-RDTs were evaluated using whole blood as well as serum
at two different conditions (At bed site and laboratory site). In this
study total 135 conﬁrmed VL cases, 85 endemic healthy with no
kala azar history, 15 malaria patients and 20 tuberculosis patients
were enrolled. The interpretation was recorded into a data sheet.
Results: Overall, our ﬁnding illustrates that different RDTs
demonstrated varied sensitivity and speciﬁcity. At ﬁeld site the
sensitivity with whole blood is ranges from 96.3% to 100% while
with serum ranges from 96.3% to 99.3%. Speciﬁcity with whole
blood ranges from 97.4% to 100%. Speciﬁcity with serum ranges
from 94.1% to 100% except onsite RevB of CTK biotech which has
lower speciﬁcity. Agreements of test result at ﬁeld site with whole
blood and serum is ranges from 0.44-0.98. At lab site the sensitiv-
ity with whole blood ranges from 94.8% to 100%. Speciﬁcity with
whole blood ranges from 95.8% to 99.2% except onsite Rev B which
has 52.9% speciﬁcity.Whilewith serum the sensitivity of all the test
ranges from97% to 99.3%. Speciﬁcitywith serum ranges from92.4%
to 98.3% except onsite Rev B has only 50.4% speciﬁcity. Agreements
of test result between whole blood and serum at lab site ranges
from 0.46 – 0.97
Conclusion: Diagnostic accuracy of different VL RDTs kits
are varies. Many test performed good sensitivity and speciﬁcity
against blood and serum sample as well as ﬁeld site and lab
site.
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